Top Markets
Coin of the day
Beta Bionics, Inc. Beta Bionics, Inc.

Beta Bionics, Inc.

BBNX
Classificação em ações #10096
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated... Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Preço da ação
$19.81
Última sincronização: 2026-08-28
Valor de mercado
$891.32M
Variação (1 dia)
1.39%
Variação (1 ano)
5.16%
País
US
Negociar Beta Bionics, Inc. (BBNX)

Categoria

Histórico de desdobramentos de ações de Beta Bionics, Inc. (BBNX)
As ações Beta Bionics, Inc. (símbolo: BBNX) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Aug 30, 2026.
Uma ação BBNX comprada antes de Aug 30, 2026 equivaleria hoje a 0 ações BBNX.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
0 -
DE